– Reuters
Citigroup Maintains Neutral on Ecolab, Raises Price Target to $164
Citigroup analyst PJ Juvekar maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $146 to $164.
Related Posts
What’s Going On With Avalo Therapeutics (AVTX) Stock?
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares are trading higher Friday. The stock appears to be recovering from a 25% drop on Thursday.
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.
Markets Turn More Bullish Following Inflation Data
The CNN Money Fear and Greed index showed an improvement in overall market sentiment following the release of US CPI data.
US stocks closed higher on Tuesday following release of lower-than-expected data on inflation.